Upconversion nanoparticles as versatile light nanotransducers for photoactivation applications.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Photochemistry

Background:

• Photoactivable drugs offer precise spatial and temporal control but are limited by UV/visible light's poor tissue penetration and UV safety concerns.
• Near-infrared (NIR) light offers deeper tissue penetration and improved safety for light-based therapies.
• Upconversion nanoparticles (UCNs) can convert NIR light to shorter wavelengths, enabling remote activation of therapeutic agents.

Purpose of the Study:

• To review recent advancements in using UCNs for photoactivation of therapeutic agents.
• To highlight the potential of UCNs in overcoming the limitations of traditional photoactivation methods.
• To discuss UCNs for photocontrolled drug delivery and photodynamic therapy.

Main Methods:

• Review of literature on UCNs and their applications in photoactivation.
• Discussion of UCNs as nanotransducers converting NIR light to shorter wavelengths (UV, visible, NIR).
• Exploration of UCNs' optical properties, including fluorescence, photobleaching, and autofluorescence.

Main Results:

• UCNs can be tuned to emit various wavelengths for different activation requirements.
• UCNs exhibit unique optical properties like near-zero photobleaching and autofluorescence, suitable for combined imaging and therapy.
• UCNs facilitate photocontrolled delivery and photodynamic therapy via activation of light-sensitive molecules or photosensitizers.

Conclusions:

• UCNs represent a promising platform for advanced photocontrolled therapeutic applications.
• The use of NIR light with UCNs enhances safety and efficacy in deep-tissue treatments.
• UCNs offer a versatile approach for targeted drug delivery and photodynamic therapy, with potential for simultaneous imaging.